RepliCel Life Sciences, Inc.: RepliCel Terminates License Agreement with Shiseido

VANCOUVER, BC / ACCESSWIRE / December 21, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FSE:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics

Related Keywords

China ,Japan ,United States ,Hong Kong ,Vancouver ,British Columbia ,Canada ,Lee Buckler ,Replicel Life Sciences Inc ,Asia To Shiseido Company ,Replicel Life Sciences ,International Center ,China Health Company ,Venture Exchange ,Regulation Services Provider ,Dispute Resolution ,Shiseido Company Limited ,Greater China ,Replicel ,Life ,Ciences ,Terminates ,License ,Agreement ,Shiseido ,